Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, C. D.
Right arrow Articles by Thomas, N. S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, C. D.
Right arrow Articles by Thomas, N. S. B.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Characterization of Cell Cycle Status and E2F Complexes in Mobilized CD34+ Cells Before and After Cytokine Stimulation

Catherine D. Williams, David C. Linch, Mike J. Watts, and N. Shaun B. Thomas

From the Department of Haematology, University College London Medical School, London, UK.

Mobilized peripheral blood progenitors (CD34+ cells) have been shown to be either in the G0 or G1 phase of the cell cycle. In this study, it is shown that they are small cells with low protein content suggestive of G0. Support for this is provided by showing that the principal E2F complex consists of hypophosphorylated p130, E2F-4, and DP-1. The E2F-4 is more highly phosphorylated than in quiescent T cells. In response to cytokines in vitro, the CD34+ cells start to enter G1 within 8 hours and enter S-phase at about 48 hours. As cells enter G1, E2F-4 is dephosphorylated to several hypophosphorylated forms and three new DNA-binding complexes appear, including one containing E2F-4, DP-1, and p107. We suggest that mobilized CD34+ cells may be maintained in G0 by p130, E2F-4, and DP-1 and the coordinate dephosphorylation of E2F-4 and hyperphosphorylation of p130 may be central to the initiation of proliferation.

Blood, Vol. 90 No. 1 (July 1), 1997: pp. 194-203
© 1997 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. Fernandez de Mattos, P. Villalonga, J. Clardy, and E. W-F. Lam
FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells
Mol. Cancer Ther., October 1, 2008; 7(10): 3237 - 3246.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Bonig, A. Wundes, K.-H. Chang, S. Lucas, and T. Papayannopoulou
Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab
Blood, April 1, 2008; 111(7): 3439 - 3441.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Kikuchi, R. Shimizu, T. Wada, H. Ando, M. Nakamura, K. Ozawa, and Y. Furukawa
E2F-6 Suppresses Growth-Associated Apoptosis of Human Hematopoietic Progenitor Cells by Counteracting Proapoptotic Activity of E2F-1
Stem Cells, October 1, 2007; 25(10): 2439 - 2447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Verkoczy, B. Duong, P. Skog, D. Ait-Azzouzene, K. Puri, J. L. Vela, and D. Nemazee
Basal B Cell Receptor-Directed Phosphatidylinositol 3-Kinase Signaling Turns Off RAGs and Promotes B Cell-Positive Selection
J. Immunol., May 15, 2007; 178(10): 6332 - 6341.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Soeiro, A. Mohamedali, H. M. Romanska, N. C. Lea, E. S. Child, J. Glassford, S. J. Orr, C. Roberts, K. N. Naresh, E.-N. Lalani, et al.
p27Kip1 and p130 Cooperate To Regulate Hematopoietic Cell Proliferation In Vivo.
Mol. Cell. Biol., August 1, 2006; 26(16): 6170 - 6184.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. Leibundgut, N. M.R. Schmitz, and A. Hirt
Catalytic Activities of G1 Cyclin-Dependent Kinases and Phosphorylation of Retinoblastoma Protein in Mobilized Peripheral Blood CD34+ Hematopoietic Progenitor Cells
Stem Cells, August 1, 2005; 23(7): 1002 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Fernandez de Mattos, A. Essafi, I. Soeiro, A. M. Pietersen, K. U. Birkenkamp, C. S. Edwards, A. Martino, B. H. Nelson, J. M. Francis, M. C. Jones, et al.
FoxO3a and BCR-ABL Regulate cyclin D2 Transcription through a STAT5/BCL6-Dependent Mechanism
Mol. Cell. Biol., November 15, 2004; 24(22): 10058 - 10071.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sunters, S. Fernandez de Mattos, M. Stahl, J. J. Brosens, G. Zoumpoulidou, C. A. Saunders, P. J. Coffer, R. H. Medema, R. C. Coombes, and E. W.-F. Lam
FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines
J. Biol. Chem., December 12, 2003; 278(50): 49795 - 49805.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Mohamedali, I. Soeiro, N. C. Lea, J. Glassford, L. Banerji, G. J. Mufti, E. W.-F. Lam, and N. S. B. Thomas
Cyclin D2 controls B cell progenitor numbers
J. Leukoc. Biol., December 1, 2003; 74(6): 1139 - 1143.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
A. Dolnikov, S. Wotherspoon, M. Millington, and G. Symonds
Retrovirus vector production and transduction: modulation by the cell cycle
J. Gen. Virol., November 1, 2003; 84(11): 3131 - 3141.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. E. Wright, S. H. Cheshier, A. J. Wagers, T. D. Randall, J. L. Christensen, and I. L. Weissman
Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle
Blood, April 15, 2001; 97(8): 2278 - 2285.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Shiotsu, K. Yamashita, F. Kanai, Y. Ikuina, C. Murakata, M. Teramura, H. Mizoguchi, T. Tamaoki, and S. Akinaga
Chemoprotective effects of KF41399, a derivative of carbazole compounds, on nimustine-induced thrombocytopenia
Blood, June 15, 2000; 95(12): 3771 - 3780.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Jiang, F. Prosper, and C. M. Verfaillie
Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors
Blood, February 1, 2000; 95(3): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. P. Persengiev, I. I. Kondova, and D. L. Kilpatrick
E2F4 Actively Promotes the Initiation and Maintenance of Nerve Growth Factor-Induced Cell Differentiation
Mol. Cell. Biol., September 1, 1999; 19(9): 6048 - 6056.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Roberts, E. Mollapour, M. J. Watts, and D. C. Linch
Primitive Myeloid Cells Express High Levels of Phospholipase A2 Activity in the Absence of Leukotriene Release: Selective Regulation by Stem Cell Factor Involving the MAP Kinase Pathway
Blood, August 15, 1999; 94(4): 1261 - 1272.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. van der Sman, N. S. B. Thomas, and E. W.-F. Lam
Modulation of E2F Complexes during G0 to S Phase Transition in Human Primary B-lymphocytes
J. Biol. Chem., April 23, 1999; 274(17): 12009 - 12016.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Herblot, P. Chastagner, L. Samady, J.-L. Moreau, C. Demaison, P. Froussard, X. Liu, J. Bonnet, and J. Theze
IL-2-Dependent Expression of Genes Involved in Cytoskeleton Organization, Oncogene Regulation, and Transcriptional Control
J. Immunol., March 15, 1999; 162(6): 3280 - 3288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. S. B. Thomas, A. R. Pizzey, S. Tiwari, C. D. Williams, and J. Yang
p130, p107, and pRb Are Differentially Regulated in Proliferating Cells and during Cell Cycle Arrest by alpha -Interferon
J. Biol. Chem., September 11, 1998; 273(37): 23659 - 23667.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. L. Yong, M. Watts, N. Shaun Thomas, A. Sullivan, S. Ings, and D. C. Linch
Transmigration of CD34+ Cells Across Specialized and Nonspecialized Endothelium Requires Prior Activation by Growth Factors and Is Mediated by PECAM-1 (CD31)
Blood, February 15, 1998; 91(4): 1196 - 1205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Glassford, M. Holman, L. Banerji, E. Clayton, G. G. B. Klaus, M. Turner, and E. W.-F. Lam
Vav Is Required for Cyclin D2 Induction and Proliferation of Mouse B Lymphocytes Activated via the Antigen Receptor
J. Biol. Chem., October 26, 2001; 276(44): 41040 - 41048.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020